[18F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [18F]FDOPA and [11C]DASB PET study in Parkinson's disease

被引:42
作者
Pavese, N. [1 ]
Simpson, B. S. [1 ]
Metta, V. [2 ,3 ,4 ]
Ramlackhansingh, A. [1 ]
Chaudhuri, K. Ray [2 ,3 ,4 ]
Brooks, D. J. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Neurosci, London, England
[2] Kings Coll London, Natl Parkinson Fdn, Ctr Excellence, London WC2R 2LS, England
[3] Lewisham Hosp NHS Trust, London, England
[4] Kings Coll London, Biomed Res Ctr, London WC2R 2LS, England
基金
英国医学研究理事会;
关键词
Positron emission tomography (PET); F-18]FDOPA; C-11]DASB serotonin Parkinson; Monoamine; Extrastriatal; F-18-DOPA PET; I-123-BETA-CIT SPECT; CONTAINING NEURONS; FLUORODOPA UPTAKE; F-18; FLUORODOPA; MIDBRAIN; DOPAMINE; BINDING; DORSAL; BRAIN;
D O I
10.1016/j.neuroimage.2011.09.034
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Brain uptake of [F-18]FDOPA, measured with PET, reflects the activity of aromatic amino acid decarboxylase, an enzyme largely expressed in monoaminergic nerve terminals. This enzyme catalyzes a number of decarboxylation reactions including conversion of L-dopa into dopamine and 5-hydroxytryptophan into serotonin. For more than 20 years [F-18]FDOPA PET has been used to assess dopaminergic nigrostriatal dysfunction in patients with Parkinson's disease (PD). More recently, however, [F-18]FDOPA PET has also been employed as a marker of serotoninergic and noradrenergic function in PD patients. In this study, we provide further evidence in support of the view that [F-18]FDOPA PET can be used to evaluate the distribution and the function of serotoninergic systems in the brain. Eighteen patients with PD were investigated with both [F-18]FDOPA and [C-11]DASB PET, the latter being a marker of serotonin transport (SERT) availability. We then assessed the relationship between measurements of the two tracers within brain serotoninergic structures. [F-18]FDOPA uptake in the median raphe nuclei complex of PD patients was significantly correlated with SERT availability in the same structure. Trends towards significant correlations between [F-18]FDOPA Ki values and [C-11]DASB binding values were also observed in the hypothalamus and the anterior cingulate cortex, suggesting a serotoninergic contribution to [F-18]FDOPA uptake in these regions. Conversely, no correlations were found in brain structures with mixed dopaminergic, serotoninergic and noradrenergic innervations, or with predominant dopaminergic innervation. These findings provide evidence that [F-18]FDOPA PET represents a valid marker of raphe serotoninergic function in PD and supports previous studies where [F-18]FDOPA PET has been used to assess serotoninergic function in PD. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:1080 / 1084
页数:5
相关论文
共 50 条
  • [21] Synthesis, radiosynthesis and first in vitro evaluation of novel PET-tracers for the dopamine transporter: [11C]IPCIT and [18F]FE@IPCIT
    Rami-Mark, Christina
    Bornatowicz, Birgit
    Fink, Cornel
    Otter, Paul
    Ungersboeck, Johanna
    Vraka, Chrysoula
    Haeusler, Daniela
    Nics, Lukas
    Spreitzer, Helmut
    Hacker, Marcus
    Mitterhauser, Markus
    Wadsak, Wolfgang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (24) : 7562 - 7569
  • [22] PET Imaging with [18F]ROStrace Detects Oxidative Stress and Predicts Parkinson's Disease Progression in Mice
    Zhu, Yi
    Kohli, Neha
    Young, Anthony
    Sheldon, Malkah
    Coni, Jani
    Rajasekaran, Meera
    Robinson, Lozen
    Chroneos, Rea
    Riley, Shaipreeah
    Guarnieri, Joseph W.
    Jose, Joshua
    Patel, Nisha
    Wallace, Douglas C.
    Li, Shihong
    Lee, Hsiaoju
    Mach, Robert H.
    McManus, Meagan J.
    ANTIOXIDANTS, 2024, 13 (10)
  • [23] An Overview of PET Radiochemistry, Part 1: The Covalent Labels 18F, 11C, and 13N
    Pichler, Verena
    Berroteran-Infante, Neydher
    Philippe, Cecile
    Vraka, Chrysoula
    Klebermass, Eva-Maria
    Balber, Theresa
    Pfaff, Sarah
    Nics, Lukas
    Mitterhauser, Markus
    Wadsak, Wolfgang
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (09) : 1350 - 1354
  • [24] Direct Comparison of [18F]F-DPA with [18F]DPA-714 and [11C]PBR28 for Neuroinflammation Imaging in the same Alzheimer's Disease Model Mice and Healthy Controls
    Lopez-Picon, Francisco R.
    Keller, Thomas
    Bocancea, Diana
    Helin, Jatta S.
    Krzyczmonik, Anna
    Helin, Semi
    Damont, Annelaure
    Dolle, Frederic
    Rinne, Juha O.
    Haaparanta-Solin, Merja
    Solin, Olof
    MOLECULAR IMAGING AND BIOLOGY, 2022, 24 (01) : 157 - 166
  • [25] Striatal Presynaptic Dopamine in Schizophrenia, Part II: Meta-Analysis of [18F/11C]-DOPA PET Studies
    Fusar-Poli, Paolo
    Meyer-Lindenberg, Andreas
    SCHIZOPHRENIA BULLETIN, 2013, 39 (01) : 33 - 42
  • [26] Fully automated synthesis of PET TSPO radioligands [11C]DAA1106 and [18F]FEDAA1106
    Wang, Min
    Gao, Mingzhang
    Zheng, Qi-Huang
    APPLIED RADIATION AND ISOTOPES, 2012, 70 (06) : 965 - 973
  • [27] [18F]NOS PET Brain Imaging Suggests Elevated Neuroinflammation in Idiopathic Parkinson's Disease
    Doot, Robert K.
    Young, Anthony J.
    Nasrallah, Ilya M.
    Wetherill, Reagan R.
    Siderowf, Andrew
    Mach, Robert H.
    Dubroff, Jacob G.
    CELLS, 2022, 11 (19)
  • [28] Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling Part II: Metabolism studies
    Peyronneau, Marie-Anne
    Saba, Wadad
    Dolle, Frederic
    Goutal, Sebastien
    Coulon, Christine
    Bottlaender, Michel
    Valette, Heric
    NUCLEAR MEDICINE AND BIOLOGY, 2012, 39 (03) : 347 - 359
  • [29] Sensitivity of Kinetic Macro Parameters to Changes in Dopamine Synthesis, Storage, and Metabolism: A Simulation Study for [18F]FDOPA PET By a Model With Detailed Dopamine Pathway
    Matsubara, Keisuke
    Watabe, Hiroshi
    Kumakura, Yoshitaka
    Hayashi, Takuya
    Endres, Christopher J.
    Minato, Kotaro
    Iida, Hidehiro
    SYNAPSE, 2011, 65 (08) : 751 - 762
  • [30] Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling Part I: PET studies
    Saba, Wadad
    Peyronneau, Marie-Anne
    Dolle, Frederic
    Goutal, Sebastien
    Bottlaender, Michel
    Valette, Heric
    NUCLEAR MEDICINE AND BIOLOGY, 2012, 39 (02) : 227 - 233